Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription

por Frigault, Melanie M., Mithal, Arushi, Wong, Harvey, Stelte-Ludwig, Beatrix, Mandava, Vinay, Huang, Xin, Birkett, Joseph, Johnson, Amy J., Izumi, Raquel, Hamdy, Ahmed
Publicado 2023